These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 25265848)
1. Synthesis and antimicrobial activities of oxazepine and oxazocine derivatives. Tang J; Jiang YL; Wang BX; Shen YM Z Naturforsch C J Biosci; 2014; 69(7-8):283-90. PubMed ID: 25265848 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and Characterization of Tetrachloro-1,3-Oxazepine Derivatives and Evaluation of their Biological Activities. Kshash AH Acta Chim Slov; 2020 Mar; 67(1):113-118. PubMed ID: 33558920 [TBL] [Abstract][Full Text] [Related]
3. [New derivatives of 7- and 8-member perhydrocyclic compounds. II. Studies on the effect on the central nervous system and circulatory system of new derivatives of perhydro-1,4-oxazepine, perhydro-1,4-diazepine, perhydro-1,4,5-oxadiazepine and perhydro-1,5-oxazocine containing the 2-guanidinoethyl group]. Szadowska A; Działek S; Kiełek MB; Kusowska J; Wejman I Acta Pol Pharm; 1985; 42(1):55-60. PubMed ID: 4040312 [No Abstract] [Full Text] [Related]
4. [Synthesis of new 7, 8 and 9-membered heterocyclic compounds containing oxygen and nitrogen as heteroatoms. III. Synthesis of new hexahydro-1,5-oxazocine derivatives with potential pharmacological activity]. Glinka R; Kotelko B Acta Pol Pharm; 1976; 33(1):39-48. PubMed ID: 1266642 [No Abstract] [Full Text] [Related]
5. [Heterocyclic amine derivatives - analogs of mebanazine, pheniprazine and phenelzine. II. Studies on the effect, on the central nervous system, of derivatives of perhydroazepine, perhydro-1,4-diazepine, perhydro-1,4-oxazepine, perhydro-1,5-oxazocine and morpholine-containing arylalkyloamine groups]. Szadowska A; Mazur M; Szmigielski A; Szmigielska H; Winer A Acta Pol Pharm; 1983; 40(1):111-8. PubMed ID: 6136156 [No Abstract] [Full Text] [Related]
7. Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors. Rao AU; Xiao D; Huang X; Zhou W; Fossetta J; Lundell D; Tian F; Trivedi P; Aslanian R; Palani A Bioorg Med Chem Lett; 2012 Jan; 22(2):1068-72. PubMed ID: 22182499 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of dibenz[b,f][1,5]oxazocine derivatives for agonist activity at κ-opioid receptor. Mitra S; Banerjee TS; Hota SK; Bhattacharya D; Das S; Chattopadhyay P Eur J Med Chem; 2011 May; 46(5):1713-20. PubMed ID: 21392859 [TBL] [Abstract][Full Text] [Related]
9. 6,7-Dihydrobenzo[f]benzo[4,5]imidazo[1,2-d][1,4]oxazepine derivatives as selective inhibitors of PI3Kα. Yin Y; Zhang YQ; Jin B; Sha S; Wu X; Sangani CB; Wang SF; Qiao F; Lu AM; Lv PC; Zhu HL Bioorg Med Chem; 2015 Mar; 23(6):1231-40. PubMed ID: 25693787 [TBL] [Abstract][Full Text] [Related]
10. Naphthoxazepine inhibitors of HIV-1 integrase: synthesis and biological evaluation. Garofalo A; Grande F; Brizzi A; Aiello F; Dayam R; Neamati N ChemMedChem; 2008 Jun; 3(6):986-90. PubMed ID: 18383063 [TBL] [Abstract][Full Text] [Related]
11. 2-substituted-4-aryl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,5]oxazocin-5-one as a structurally new NK1 antagonist. Seto S; Tanioka A; Ikeda M; Izawa S Bioorg Med Chem Lett; 2005 Mar; 15(5):1485-8. PubMed ID: 15713412 [TBL] [Abstract][Full Text] [Related]
12. Investigations of anthelminthic activity and synthesis of new derivatives of perhydroazepine, perhydro-1,4-diazepine, perhydro-1,4-oxazepine and perhydro-1,5-oxazocine. Glinka R; Grzywacz M; Kotełko B; Majchrzak M; Malinowski H; Mikołajewska H; Mikiciukolasik E; Szkukliński J Pol J Pharmacol Pharm; 1980; 32(5):773-7. PubMed ID: 7196575 [TBL] [Abstract][Full Text] [Related]
13. [Synthesis of derivatives of perhydroazepine, perhydro-1,5-oxazocine, morpholine and piperazine containing 3-(isopropylamino)-propan-2-ol group--compounds with potential effect on the circulatory system and central nervous system]. Kotełko B; Mikołajewska H; Glinka R; Guryn R Acta Pol Pharm; 1985; 42(5):433-6. PubMed ID: 3834763 [No Abstract] [Full Text] [Related]
14. Amino acid based enantiomerically pure 3-substituted benzofused heterocycles: A new class of antithrombotic agents. Mishra JK; Samanta K; Jain M; Dikshit M; Panda G Bioorg Med Chem Lett; 2010 Jan; 20(1):244-7. PubMed ID: 19932967 [TBL] [Abstract][Full Text] [Related]
15. Antibacterial Activity and Structure-Activity Relationship of a Series of Newly Synthesized Pleuromutilin Derivatives. Li YG; Wang JX; Zhang GN; Zhu M; You XF; Hu XX; Zhang F; Wang YC Chem Biodivers; 2019 Feb; 16(2):e1800560. PubMed ID: 30467968 [TBL] [Abstract][Full Text] [Related]
16. Pyrimido-oxazepine as a versatile template for the development of inhibitors of specific kinases. Pan W; Liu H; Xu YJ; Chen X; Kim KH; Milligan DL; Columbus J; Hadari YR; Kussie P; Wong WC; Labelle M Bioorg Med Chem Lett; 2005 Dec; 15(24):5474-7. PubMed ID: 16198560 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticonvulsant evaluation of 6-amino-1,4-oxazepane-3,5-dione derivatives. Sharma G; Park JY; Park MS Arch Pharm Res; 2008 Jul; 31(7):838-42. PubMed ID: 18704324 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of 10-alkoxy-5, 6-dihydro-triazolo[4,3-d]benzo[f][1,4]oxazepine derivatives with anticonvulsant activity. Deng XQ; Wei CX; Li FN; Sun ZG; Quan ZS Eur J Med Chem; 2010 Jul; 45(7):3080-6. PubMed ID: 20416982 [TBL] [Abstract][Full Text] [Related]
19. Naphtho[2,1-b][1,5] and [1,2-f][1,4]oxazocines as selective NK1 antagonists. Ohnmacht CJ; Albert JS; Bernstein PR; Rumsey WL; Masek BB; Dembofsky BT; Koether GM; Andisik DW; Aharony D Bioorg Med Chem; 2004 May; 12(10):2653-69. PubMed ID: 15110847 [TBL] [Abstract][Full Text] [Related]
20. Analysis of crucial structural requirements of 2-substituted pyrimido[4,5-b][1,5]oxazocines as NK(1) receptor antagonist by axially chiral derivatives. Seto S; Asano J Bioorg Med Chem; 2007 Aug; 15(15):5083-9. PubMed ID: 17540575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]